Hjem › Fokal segmental glomerulosklerose › North Carolina
Fokal segmental glomerulosklerose kliniske forsøg i North Carolina
9 studier for Fokal segmental glomerulosklerose søger deltagere på steder i North Carolina.
Byer i North Carolina
Officiel studietekst (engelsk)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #16, New Bern
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Duke University Medical Center, Durham
- Carolina Kidney Associates, Greensboro
- Cardinal Clinical Research, LLC - Shelby, Shelby
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- UNC Kidney Center- Site Number : 8400021, Chapel Hill
RekruttererFase 2
Alder 16 til 75 · Alle køn · Opdateret 23. sep. 2026 · NCT06500702Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- University of North Carolina, Chapel Hill
Rekrutterer
Op til 75 år · Alle køn · Opdateret 28. aug. 2026 · NCT04065438Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- University of North Carolina, Chapel Hill
Rekrutterer
Op til 21 år · Alle køn · Opdateret 28. aug. 2026 · NCT02235857Nephrotic Syndrome Study Network
- University of North Carolina at Chapel Hill, Chapel Hill
- Atrium Health Levine Children's Hospital, Charlotte
RekruttererObservationsstudie
Op til 80 år · Alle køn · Opdateret 10. jun. 2026 · NCT01209000NEPTUNE Match Study
- University of North Carolina Chapel Hill, Chapel Hill
Rekrutterer
Alder 1 til 80 · Alle køn · Opdateret 10. jun. 2026 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke Molecular Physiology Institute, Durham
RekruttererFase 2
Alder 1 til 17 · Alle køn · Opdateret 12. maj 2026 · NCT05003986A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- University of North Carolina, Chapel Hill
- Atrium Health, Charlotte
RekruttererFase 3
Alder 12 til 80 · Alle køn · Opdateret 3. feb. 2026 · NCT05183646Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.